Kevin R. Kozak

AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

Tracy T. Batchelor, A. Gregory Sorensen, Emmanuelle di Tomaso et al. · Cancer Cell · 2007 · 1.8K citations · Full text

Medicine, Oncology, Pharmacology +17

Oxygenation of the Endocannabinoid, 2-Arachidonylglycerol, to Glyceryl Prostaglandins by Cyclooxygenase-2

Kevin R. Kozak, Scott W. Rowlinson, Lawrence J. Marnett · Journal of Biological Chemistry · 2000 · 392 citations · Full text

Life Sciences, Biochemistry, Pharmacology +14

Metabolism of the Endocannabinoids, 2-Arachidonylglycerol and Anandamide, into Prostaglandin, Thromboxane, and Prostacyclin Glycerol Esters and Ethanolamides

Kevin R. Kozak, Brenda C. Crews, Jason D. Morrow et al. · Journal of Biological Chemistry · 2002 · 363 citations · Full text

Life Sciences, Biochemistry, Pharmacology +14

A Novel Mechanism of Cyclooxygenase-2 Inhibition Involving Interactions with Ser-530 and Tyr-385

Scott W. Rowlinson, James R. Kiefer, Jeffery J. Prusakiewicz et al. · Journal of Biological Chemistry · 2003 · 347 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: Facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors

Amit S. Kalgutkar, Brenda C. Crews, Scott W. Rowlinson et al. · Proceedings of the National Academy of Sciences · 2000 · 252 citations

Medicine, Medicinal Chemistry, Pharmacology +15